Who
Cristian Massacesi
EVP,Chief Med Offr,Head of Dev
Company insider
Files Form 4 as: EVP,Chief Med Offr,Head of Dev, Bristol-Myers Squibb.
In numbers
- Trades disclosed
- 13
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $807K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Aug 2025
- Last trade
- 9 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Sep – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 10 Sep 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Sold | $403K6,249 at $64.57 | filing |
| 9 Sep 2026filed 10 Sep 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Sold | $403K6,249 at $64.57 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code M | —51,172 at $0.00 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code F | $1.7M26,175 at $65.31 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —51,172 at $0.00 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —51,172 at $0.00 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code M | —51,172 at $0.00 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code F | $1.7M26,175 at $65.31 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —26,122 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —39,184 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —26,122 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —39,184 at $0.00 | filing |
| 1 Aug 2025filed 5 Aug 2025 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —204,691 at $0.00 | filing |
News
Bristol Myers Squibb's Cancer Drug Just Doubled Survival Time Without Progression — Here's Why It MattersBMY · fool.com · 27 Oct 2026Bristol Myers Squibb: Bargain Buy or Value Trap?BMY · fool.com · 26 Oct 2026Should You Buy Bristol Myers Squibb While It Trades Below 10 Times Forward Earnings?BMY · fool.com · 25 Oct 2026
0 headlines in the last 90 days name Cristian Massacesi; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.